Acupressure for Cough in Lung Cancer Survivors
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer.
The hypotheses are:
1. Acupressure can alleviate cough in lung cancer survivors; 2. Acupressure can reduce a cough-related symptom cluster (dyspnea-cough-fatigue) experienced by lung cancer survivors; 3. Acupressure can reduce the symptom burden and improve the health-related quality of life and functional capacity of lung cancer survivors experiencing cough.
Participants will:
Receive acupressure for 8 weeks or receive an education booklet; Keep a diary of their acupressure practice and symptoms; Be assessed at baseline (T0), early intervention (T1), post-intervention (T2), and 8 weeks after the intervention period (T3).
Eligibility criteria
Qualifiers
be at least 18 years of age;
have a diagnosis of LC at any stage and of any pathological type;
have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
can perform acupressure independently in daily activities;
Disqualifiers
have unstable chronic diseases other than LC;
have received acupressure or acupuncture within the three months preceding study enrollment;
have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
have a life expectancy of less than 3 months;
Trial design
Treatments tested in this trial
- acupressure
- Education
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
The University of Hong Kong
Lead sponsor
The University of Hong Kong-Shenzhen Hospital
Collaborator
Queen Mary Hospital, Hong Kong
Collaborator
Source ClinicalTrials.gov